<DOC>
	<DOC>NCT01738373</DOC>
	<brief_summary>The aim of this registry is to provide information, in day-to-day practice, on Plerixafor prescription modalities in France, over a 13-month period in order to address the health authorities' request.</brief_summary>
	<brief_title>Registry of Patients Treated With Plerixafor (MozobilÂ®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation</brief_title>
	<detailed_description />
	<mesh_term>JM 3100</mesh_term>
	<criteria>Patients treated with Plerixafor for autologous transplantation between November 2011 and November 2012 Patients who have been informed and who have given their written consent for the access to their medical file Patients already included in a Plerixafor ongoing clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>autologous stem cell transplantation</keyword>
	<keyword>lymphoma</keyword>
	<keyword>multiple myeloma</keyword>
</DOC>